IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 202 filers reported holding IMMUNOGEN INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,228,975 | -12.4% | 392,500 | +4.1% | 0.05% | -21.3% |
| Q2 2023 | $7,113,405 | +1505.7% | 376,969 | +307.1% | 0.06% | +1425.0% |
| Q3 2022 | $443,000 | +8.0% | 92,603 | +67.2% | 0.00% | 0.0% |
| Q4 2021 | $410,000 | +594.9% | 55,400 | +154.1% | 0.00% | +100.0% |
| Q1 2019 | $59,000 | -22.4% | 21,800 | +38.0% | 0.00% | -33.3% |
| Q4 2018 | $76,000 | -98.6% | 15,800 | -98.2% | 0.00% | -99.3% |
| Q4 2017 | $5,547,000 | -24.4% | 865,356 | -9.8% | 0.45% | -32.2% |
| Q3 2017 | $7,336,000 | -9.2% | 958,845 | -15.6% | 0.67% | -19.6% |
| Q2 2017 | $8,080,000 | +103.6% | 1,136,394 | +10.8% | 0.83% | +109.3% |
| Q1 2017 | $3,968,000 | +151.0% | 1,025,176 | +32.3% | 0.40% | +94.1% |
| Q4 2016 | $1,581,000 | – | 775,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 13,063,767 | $35,403,000 | 1.04% |
| QVT Financial LP | 1,375,900 | $3,442,000 | 0.87% |
| Virtus ETF Advisers LLC | 50,045 | $136,000 | 0.29% |
| Fernwood Investment Management, LLC | 187,000 | $507,000 | 0.27% |
| PURA VIDA INVESTMENTS, LLC | 524,600 | $1,422,000 | 0.20% |
| Endurant Capital Management LP | 184,440 | $500,000 | 0.20% |
| Birchview Capital, LP | 90,000 | $244,000 | 0.15% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 112,873 | $306,000 | 0.14% |
| DLD Asset Management, LP | 1,239,500 | $3,347,000 | 0.12% |
| DLD Asset Management, LP | 1,186,300 | $3,215,000 | 0.12% |